The Evaluation of Chenopodium Formosanum and Fagopyrum Esculentum Extract on Anti-aging Effect

TCI

Status

Completed

Conditions

Skin Condition

Treatments

Dietary Supplement: Placebo drink

Dietary Supplement: Chenopodium Formosanum and Fagopyrum Esculentum Extract drink

Study type

Interventional

Funder types

Industry

Identifiers

CMUH108-REC1-147

Details and patient eligibility

About

To assess Chenopodium Formosanum and Fagopyrum Esculentum Extract on skin anti-aging

Enrollment

50 patients

Sex

All

Ages

20 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Healthy adults aged between 20-65 years old
Subjects must read and sign the informed consent form after the study has been fully explained.
Subjects are willing to cooperate and comply with all of the regulation during the trial.
Subject should inform to investigator immediately if adverse effect is happened.
Subjects are willing to avoid UV overexposure during the trial (include indoor tanning treatment).

Exclusion criteria

Subjects who have known cosmetic, drug or food allergies.
Subjects who have severe desquamation, tattoo, sunburn, peeling skin or other skin condition might impact measurement.
Subjects with any physical condition judged by the researcher not to be eligible for this study.
Subjects with uncontrollable physical condition such as high blood pressure, thyroid disease, diabetes, etc.
Female who is pregnant or nursing or planning to become pregnant during the course of the study.
Those who are currently participating in other clinical trials or who have just concluded a clinical trial two weeks ago.
Women who have started contraceptive or change current hormone contraceptive methods within 3 months.